DVAX vs WRK
Dynavax Technologies Corporation (DVAX) versus WRK (WRK) — a side-by-side from cached financials, not a winner call.
Dynavax Technologies Corporation (DVAX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
WRK (WRK) common stock.
Latest reported DVAX revenue for 2024-12-31 was $277.2M. Net income was $27.3M. Revenue was up 19.4% from 2023-12-31 to 2024-12-31. DVAX currently screens at market cap $1.82B.
WRK does not have a complete income-statement cache yet.
DVAX currently screens at market cap $1.82B.
Not investment advice. Open the DVAX and WRK stock pages for the full models.
Not investment advice.